Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/AMPH
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Amphastar Pharmaceuticals Inc (AMPH) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

AMPH trades at $19.98, down 2.15% today, with a bullish technical signal from moving averages and ADX. Recent Q2 2026 earnings beat EPS estimates at $0.91 vs. $0.62 expected, though Q1 and Q4 2025 missed. The company shows solid fundamentals with a P/E of 11.82, net income margin of 10.76%, and positive cash flow growth, supported by new product launches like generic Atrovent.
Outlook is mixed: growth from proprietary drugs and biosimilars offers upside, but risks include an FDA warning letter, competitive pressures, and potential tariff impacts on generics. Analyst consensus is cautious with 25% buy ratings, reflecting balanced opportunities and headwinds for investors.
Read full analysis

Key Stats

  • Market Cap
    $858.42M
  • Volume
    -
  • Sector
    Health
  • 52W High
    $30.81
  • 52W Low
    $16.87
  • Typical Hold Time
    -
  • Enterprise Value
    $1.26B
  • Div Yield
    -
  • Trading Activity
    -
$20.98
52W Low: $16.87
15 May 2026
52W High: $30.81
02 Sep 2025

Track Amphastar Pharmaceuticals Inc (AMPH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Amphastar Pharmaceuticals Inc has traded between a low of $16.87 and a high of $30.81, highlighting its annual price range. Buy and sell Amphastar Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Amphastar Pharmaceuticals Inc

Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.

Most Recent News

Content is generated by Aura AI

Inovio advances DNA medicine pipeline with FDA review of INO-3107 and $18.3M funding secured

Inovio Pharmaceuticals is progressing its DNA medicine pipeline with its lead candidate INO-3107 for Recurrent Respiratory Papillomatosis under FDA accelerated review, targeting a decision by October 30, 2026. The company raised $18.3 million in fund...

Market News
1 hour ago
Alex Lavoie
Bullish
news icon
pluang ai news

Life360 director Morin Brit sells 15,582 shares for $1 million

Morin Brit, a director at Life360, sold 15,582 shares of the company, generating $1 million from the transaction. This sale may indicate a personal financial decision or portfolio adjustment by the director. Investors might watch for any further insi...

Market News
2 hours ago
Josh Kohn-Lindquist
Bearish
news icon
pluang ai news

AbCellera's stock jumps after successful menopause drug trial and CFO insider buying.

AbCellera Biologics announced positive Phase 2 trial results for its experimental menopause drug ABCL635, which significantly reduced hot flash frequency by 83%. The stock surged 33.19% to a 52-week high of $11.32, boosting the company's market cap t...

Market News
2 hours ago
Alex Lavoie
Bullish
news icon
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $858.42M
  • Volume
    -
  • Sector
    Health
  • 52W High
    $30.81
  • 52W Low
    $16.87
  • Typical Hold Time
    -
  • Enterprise Value
    $1.26B
  • Div Yield
    -
  • Trading Activity
    -
$20.98
52W Low: $16.87
15 May 2026
52W High: $30.81
02 Sep 2025

Track Amphastar Pharmaceuticals Inc (AMPH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Amphastar Pharmaceuticals Inc has traded between a low of $16.87 and a high of $30.81, highlighting its annual price range. Buy and sell Amphastar Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!